Lennar Cuts Full-Year Outlook as Margins and New Orders Continue to Slip

What happened

Lennar cut its full-year outlook after reporting Q2 2026 EPS of $1.24 ($1.31 excluding mark-to-market losses), below expectations and down from prior quarters. The stock fell 2.37% premarket as homebuilding gross margins and new orders weakened further, underscoring persistent affordability pressures. This marks continued margin compression from 22.5% in Q3 2024 to 17.0% in Q4 2025 and now lower in Q2 2026. Management's guidance implies that structural headwinds from ~14% incentives and elevated land costs are more entrenched than hoped. With EPS trending below $2 per quarter, the path to normalized earnings near $7–$8 appears increasingly uncertain, reinforcing the potential sell thesis.

Implication

The Q2 results and reduced full-year guidance validate the bear case: incentives remain stuck near 14% and gross margins are trending below 15% rather than stabilizing mid-teens. With EPS running at a ~$5 run-rate and likely to decline further, the stock's $119 price implies ~24x forward P/E on depressed earnings, leaving no margin of safety. Investors should expect further downward revisions as the market reprices the stock toward the DeepValue report's attractive entry of $95. The Millrose spin-off and land-light model cannot quickly offset fundamental demand weakness, and any margin recovery is unlikely before late 2027 without a sharp drop in mortgage rates. Reallocate capital to better-positioned cyclicals or wait for a deeper discount—risk-reward favors sellers at current levels.

Thesis delta

The Q2 2026 earnings miss and full-year outlook cut materially increase the probability of the bear case scenario (30% → 45%), where gross margins stay at 13-14% and EPS remains below $6 for multiple years. The prior assumption of a mid-teens margin trough by end of FY26 is now delayed to FY27 or beyond, as incentives show no sign of abating even with mortgage rates around 6%. This reinforces the POTENTIAL SELL rating and extends the re-assessment window to 12-18 months.